{'fraction_non_alphanumeric': 0.020028612303290415, 'fraction_numerical': 0.005722460658082976, 'mean_word_length': 6.608695652173913, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A Novel Mitochondrial Fission Inhibitor Ameliorates DSS and DNBS Induced Murine Colitis

Inflammatory bowel disease (IBD) encompasses a group of disorders that involve an exaggerated immune response to intestinal microbes. Maintenance of intestinal epithelial barrier function is highly dependent on normal mitochondrial networks. When the barrier is compromised, excessive pathological fission ensues via the enzyme dynamin related protein‐1 (DRP1) and its interaction with the receptor fission protein‐1 (Fis1), creating fragmented networks of mitochondria. Fragmented mitochondrial networks have impaired respiratory capacity, generate elevated reactive oxygen species and exacerbate inflammation